We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+9.87%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$299M
AUM Growth
-$469K
Cap. Flow
-$27M
Cap. Flow %
-9.03%
Top 10 Hldgs %
39.8%
Holding
92
New
15
Increased
30
Reduced
32
Closed
15

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$9.95M
2
EHC icon
Encompass Health
EHC
+$8.69M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.99M
4
BIIB icon
Biogen
BIIB
+$5.15M
5
PFE icon
Pfizer
PFE
+$4.29M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$10.6M
2
GMED icon
Globus Medical
GMED
+$10.3M
3
MRK icon
Merck
MRK
+$10.2M
4
BDX icon
Becton Dickinson
BDX
+$8.54M
5
STJ
St Jude Medical
STJ
+$7.48M

Sector Composition

Rank Sector Weight
1 Healthcare 89.39%
2 Financials 3.11%
3 Technology 0.63%
4 Industrials 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALPN
76
DELISTED
Alpine Immune Sciences Inc
ALPN
$240K 0.08%
7,746
+175
+2% +$5.97K
TRIL
77
DELISTED
Trillium Therapeutics Inc.
TRIL
$158K 0.05%
+12,500
New +$174K
AMGN icon
78
Amgen
AMGN
$208B
– –
-15,800
Closed -$2.19M
COR icon
79
Cencora
COR
$60.6B
– –
-12,904
Closed -$1.23M
CYH icon
80
Community Health Systems
CYH
$393M
– –
-52,635
Closed -$1.86M
EW icon
81
Edwards Lifesciences
EW
$49.6B
– –
-16,200
Closed -$384K
JAZZ icon
82
Jazz Pharmaceuticals
JAZZ
$15.9B
– –
-10,500
Closed -$1.4M
RVTY icon
83
Revvity
RVTY
$12.6B
– –
-78,100
Closed -$3.59M
XRAY icon
84
Dentsply Sirona
XRAY
$2.68B
– –
-34,162
Closed -$1.73M
VIRX
85
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-919
Closed -$156K
PTLA
86
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-8,700
Closed -$371K
KTWO
87
DELISTED
K2M Group Holdings, Inc
KTWO
– –
-63,433
Closed -$1.18M
KND
88
DELISTED
Kindred Healthcare
KND
– –
-230,900
Closed -$3.64M
ELOS
89
DELISTED
Syneron Medical Ltd
ELOS
– –
-119,545
Closed -$855K
HTWR
90
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
– –
-4,000
Closed -$209K
TRNX
91
DELISTED
TORNIER N V SHARES (NLD)
TRNX
– –
-23,468
Closed -$479K
BCR
92
DELISTED
CR Bard Inc.
BCR
– –
-19,899
Closed -$3.71M
1 2 3
4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Endurant Capital Management held 92 positions worth $299M, down 0.16% from $300M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Endurant Capital Management withdrew a net $27M in Q4 2015, closing 15 positions and reducing 32 holdings. Its most notable exit was CR Bard Inc., an estimated $3.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 89% a quarter earlier, followed by Financials and Technology.

Against the trend, Endurant Capital Management opened a new position in Pfizer worth $4.17M.

  • Endurant Capital Management's largest Q4 2015 buy was Pfizer: 136,282 shares worth $4.17M.
  • Endurant Capital Management added most to Zimmer Biomet in Q4 2015, an estimated $9.95M increase.
  • Endurant Capital Management's biggest Q4 2015 reduction was Thermo Fisher Scientific, cutting an estimated $10.6M.
  • Endurant Capital Management fully exited CR Bard Inc. in Q4 2015, selling an estimated $3.71M.
  • Endurant Capital Management's ten largest holdings make up 40% of its $299M portfolio in Q4 2015.
  • Endurant Capital Management opened 15 new positions and closed 15 in Q4 2015.
  • Endurant Capital Management's portfolio value fell 0.16% quarter-over-quarter to $299M.

Based on Endurant Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.